Pharma major Lupin announced the successful completion of an inspection carried out by the USFDA at its Nagpur facility. The inspection concluded without any observations. Lupin’s Nagpur facility is the company’s latest facility and manufactures oral solid products. – Medical Buyer Bureau

10 Diagnostic Imaging Trends for 2018



Digital version